Abstract | BACKGROUND: OBJECTIVE: METHODS: Plasma sterol concentrations were measured by gas chromatography/mass spectrometry, and LDL-C by direct assay. RESULTS: Of 207,926 subjects tested, 4.3% had LDL-C ≥190 mg/dL. Plasma β- sitosterol concentrations ≥8.0 mg/L (99th percentile) were found in 4.3% of these subjects vs 0.72% with LDL-C <130 mg/dL. Among all subjects, 0.050% had β- sitosterol levels ≥15.0 mg/L, consistent with sitosterolemia, while among those with LDL-C ≥190 mg/dL, 0.334% had this rare disorder. A 13-year-old boy with the highest LDL-C (679 mg/dL) of all subjects had planar xanthomas and a β- sitosterol level of 53.5 mg/L (normal <3.3 mg/L). He was a compound heterozygote for 2 ABCG8 mutations (p.N409D and an intron 11+2T>A splice site mutation). On a low- cholesterol and plant-sterol diet, his LDL-C decreased to 485 mg/dL (-29%) and β- sitosterol to 44.6 mg/L (-27%). On atorvastatin 20 mg/d, his LDL-C decreased to 299 mg/dL (-38%). With added ezetimibe 10 mg/d, his LDL-C normalized to 60 mg/dL (-80% further decrease); and his β- sitosterol decreased to 14.1 mg/L (-68% further decrease). CONCLUSIONS: Our data indicate that about 4% of subjects with LDL-C concentrations ≥190 mg/dL have plasma β- sitosterol concentrations above the 99th percentile and about 0.3% have concentrations consistent with sitosterolemia. Therefore, this diagnosis should be considered in such patients.
|
Authors | Eliot A Brinton, Paul N Hopkins, Robert A Hegele, Andrew S Geller, Eliana Y Polisecki, Margaret R Diffenderfer, Ernst J Schaefer |
Journal | Journal of clinical lipidology
(J Clin Lipidol)
2018 Jan - Feb
Vol. 12
Issue 1
Pg. 152-161
ISSN: 1933-2874 [Print] United States |
PMID | 29169939
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2017. Published by Elsevier Inc. |
Chemical References |
- ABCG8 protein, human
- ATP Binding Cassette Transporter, Subfamily G, Member 8
- Anticholesteremic Agents
- Cholesterol, LDL
- Phytosterols
- Sitosterols
- gamma-sitosterol
- Ezetimibe
|
Topics |
- ATP Binding Cassette Transporter, Subfamily G, Member 8
(genetics)
- Adolescent
- Adult
- Aged
- Anticholesteremic Agents
(therapeutic use)
- Cholesterol, LDL
(blood)
- Diet, Fat-Restricted
- Ezetimibe
(therapeutic use)
- Female
- Heterozygote
- Humans
- Hypercholesterolemia
(blood, complications, diagnosis, drug therapy)
- Intestinal Diseases
(blood, complications, diagnosis)
- Lipid Metabolism, Inborn Errors
(blood, complications, diagnosis)
- Male
- Middle Aged
- Phytosterols
(adverse effects, blood)
- Sitosterols
(blood)
|